Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine

Publisher： John Wiley & Sons Inc

E-ISSN： 1439-0507|42|S2|101-104

ISSN： 0933-7407

Source： MYCOSES (ELECTRONIC), Vol.42, Iss.S2, 1999-12, pp. : 101-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Invasive Pulmonary Aspergillosis in Neutropenic Patients by Additional Bronchoscopic Amphotericin B Instillation

By  

Respiration, Vol. 74, Iss. 6, 2007-07 ,pp. : 663-673

Karger

Access to resources Recommend Favorite

Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: Fluconazole, liposomal amphotericin B, caspofungin, and voriconazole

By Manfredi Roberto   Sabbatani Sergio  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 10, 2006-10 ,pp. : 950-951

Informa Healthcare

Access to resources Recommend Favorite